Datwyler's Expert Perspective on China Pharmacopoeia, USP 382, and EU Annex 1 Compliance
The Suzhou Dialogue, convened by the China National Pharmaceutical Packaging Association, is one of China's most substantive forums for packaging regulatory dialogue — where manufacturers, regulators, and suppliers work through the complex, evolving compliance landscape together. Datwyler participates to share our expertise on the regulatory requirements that matter most to Chinese manufacturers with global ambitions: China Pharmacopoeia standards for elastomeric components, USP 382 expectations for plastic and elastomeric packaging, and EU Annex 1 sterile manufacturing requirements. Our team brings the technical documentation, the global regulatory track record, and the collaborative approach to help Chinese pharmaceutical manufacturers navigate multi-market compliance with confidence.
Explore the solutions and technologies most relevant to this event.
Access additional materials and information related to this event and Datwyler’s solutions.